Anisodamine combined with lidocaine improves healing of myocardial ischemia reperfusion injury in rats via PI3K/Akt signaling pathway

Purpose: To study the effects of anisodamine (Ad) combined with lidocaine (Ldc) on myocardial ischemia-reperfusion injury (MIRI) in rats, and its correlation with PI3K/AKT signaling pathway. Methods: A total of 70 healthy rats were randomly divided into S group, M group, Ad group, Ldc group, Ad + Ldc group, Ad + Ldc + LY group, and LY group. The cardiac hemodynamic indices in each group were determined, and the area of myocardial infarction measured. Serum biochemical indices were also determined. Furthermore, the protein expressions of p-Akt, T-Akt, Bcl-2, and Bax in myocardial cells were determined by Western blotting. Results: Compared with those in M group, Ad group, Ldc group, Ad + Ldc + LY group, and LY group, cardiac hemodynamic indices significantly improved, while the area of myocardial infarction was significantly reduced (p < 0.01). Furthermore, serum malondialdehyde (MDA) concentration but the activities of CK, CK-MB, TNF-alpha, and IL-6 declined, while the activities of superoxide dismutase (SOD), CAT and GSH-Px rose in Ad + Ldc group (p < 0.01). In Ad + Ldc group, p-Akt, T-Akt, and Bcl-2 increased, while Bax significantly decreased. Through comparison LY294002 significantly inhibited the protective effect of Ad combined with Ldc against MIRI in rats (p < 0.01). Conclusion: Anisodamine combination with lidocaine has a protective effect against MIRI in rats via PI3K/Akt signaling pathway, thus indicating that it is a potential therapeutic strategy for the management of myocardial ischemia-reperfusion.